Association of plasma cystatin C levels with angiographically documented coronary artery disease in patients of Indian origin

Journal of Cardiology

Volumn 59, Issue 2, 2012, Pages 182-189

  Batra, Aditya ^a   Kapoor, Aditya ^a   Sharma, R K ^a   Agrawal, Nitin ^a   Sinha, Archana ^a   Kumar, Sudeep ^a   Garg, Naveen ^a   Tewari, Satyendra ^a   Goel, Pravin K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Angiography; Coronary artery disease; Cystatin C; Kidney

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYSTATIN C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DEVELOPING COUNTRY; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; INDIAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RACE DIFFERENCE; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS;

BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CYSTATIN C; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INDIA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84862813763     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2011.11.013     Document Type: Article

References (31)

1. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
2. Weiner D.E., Tighiouart H., Amin M.G., Stark P.C., MacLeod B., Griffith J.L., Salem D.N., Levey A.S., Sarnak M.J. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004, 15:1307-1315.
3. Muntner P., He J., Hamm L., Loria C., Whelton P.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002, 13:745-753.
4. Manjunath G., Tighiouart H., Ibrahim H., MacLeod B., Salem D.N., Griffi{ligature}th J.L., Coresh J., Levey A.S., Sarnak M.J. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 2003, 41:47-55.
5. Shlipak M.G., Heidenreich P.A., Noguchi H., Chertow G.M., Browner W.S., McClellan M.B. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002, 137:555-562.
6. Edwards N.C., Steeds R.P., Ferro C.J., Townend J.N. The treatment of coronary artery disease in patients with chronic kidney disease. Quart J Med 2006, 99:723-736.
7. Culleton B.F., Larson M.G., Evans J.C., Wilson P.W., Barrett B.J., Parfrey P.S., Levy D. Prevalence and correlates of elevated serum creatinine levels: The Framingham Heart Study. Arch Intern Med 1999, 159:1785-1790.
8. Stevens L.A., Levey A.S. Clinical implications of estimating equations for glomerular filtration rate. Ann Intern Med 2004, 141:959-961.
9. Coll E., Botey A., Alvarez L., Poch E., Quintó L., Saurina A., Vera M., Piera C., Darnell A. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 2000, 36:29-34.
10. Weber J.A., Zanten A.P. Interferences in current methods for measurements of creatinine. Clin Chem 1991, 37:695-700.
11. Laterza O.F., Price C.P., Scott M.G., Cystatin C. An improved estimator of glomerular filtration rate?. Clin Chem 2002, 48:699-707.
12. Arpegård J., Ostergren J., de Faire U., Hansson L.O., Svensson P., Cystatin C. A marker of peripheral atherosclerotic disease?. Atherosclerosis 2008, 199:397-401.
13. Koenig W., Twardella D., Brenner H., Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 2005, 51:321-327.
14. Jernberg T., Lindahl B., James S., Larsson A., Hansson L.O., Wallentin L., Cystatin C. A novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004, 110:2342-2348.
15. Ge C., Ren F., Lu S., Ji F., Chen X., Wu X. Clinical prognostic significance of plasma cystatin C levels among patients with acute coronary syndrome. Clin Cardiol 2009, 32:644-648.
16. Deo R., Shlipak M.G., Ix J.H., Ali S., Schiller N.B., Whooley M.A. Association of cystatin C with ischemia in patients with coronary heart disease. Clin Cardiol 2009, 32:E18-E22.
17. Kim E.H., Yu J.H., Lee S.A., Kim E.Y., Kim W.G., Lee S.H., Cho E.H., Koh E.H., Lee W.J., Kim M.S., Park J.Y., Lee K.U. Lack of association between serum cystatin C levels and coronary artery disease in diabetic patients. Korean Diabetes J 2010, 34:95-100.
18. Shimizu-Tokiwa A., Kobata M., Io H., Kobayashi N., Shou I., Funabiki K., Fukui M., Horikoshi S., Shirato I., Saito K., Tomino Y. Serum cystatin C is a more sensitive marker of glomerular function than serum creatinine. Nephron 2002, 92:224-226.
19. Luc G., Bard J.M., Lesueur C., Arveiler D., Evans A., Amouyel P., Ferrieres J., Juhan-Vague I., Fruchart J.C., Ducimetiere P. Plasma cystatin-C and development of coronary heart disease: the PRIME study. Atherosclerosis 2006, 185:375-380. PRIME Study Group.
20. Rahman M., Pressel S., Davis B.R., Nwachuku C., Wright J.T., Whelton P.K., Barzilay J., Batuman V., Eckfeldt J.H., Farber M.A., Franklin S., Henriquez M., Kopyt N., Louis G.T., Saklayen M., et al. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 2006, 144:172-180.
21. Perrone R.D., Madias N.E., Levey A.S. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992, 38:1933-1953.
22. Zahran A., El-Husseini A., Shoker A. Can cystatin C replace creatinine to estimate glomerular filtration rate? A literature review. Am J Nephrol 2007, 27:197-205.
23. Koc M., Batur M.K., Karaarslan O., Abali G. Clinical utility of serum cystatin C in predicting coronary artery disease. Cardiol J 2010, 17:374-380.
24. Ichimoto E., Jo K., Kobayashi Y., Inoue T., Nakamura Y., Kuroda N., Miyazaki A., Komuro I. Prognostic significance of cystatin C in patients with ST-elevation myocardial infarction. Circ J 2009, 73:1669-1673.
25. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernández-Avilés F., Fox K.A., Hasdai D., Ohman E.M., Wallentin L., Wijns W. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007, 28:1598-1660. Task Force for Diagnosis, Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of European Society of Cardiology.
26. Wang J., Sim A.S., Wang X.L., Salonikas C., Moriatis M., Naidoo D., Wilcken D.E. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease. Atherosclerosis 2008, 197:853-859.
27. Herget-Rosenthal S., Trabold S., Pietruck F., Holtmann M., Philipp T., Kribben A., Cystatin C. Efficacy as screening test for reduced glomerular filtration rate. Am J Nephrol 2000, 20:97-102.
28. Shlipak M.G., Sarnak M.J., Katz R., Fried L.F., Seliger S.L., Newman A.B., Siscovick D.S., Cystatin Stehman-Breen C. C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005, 352:2049-2060.
29. Keller T., Messow C.M., Lubos E., Nicaud V., Wild P.S., Rupprecht H.J., Bickel C., Tzikas S., Peetz D., Lackner K.J., Tiret L., Münzel T.F., Blankenberg S., Cystatin Schnabel R.B. C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function: results from the AtheroGene study. Eur Heart J 2009, 30:314-320.
30. Sekizuka H., Akashi Y.J., Kawasaki K., Yamauchi M., Musha H., Cystatin C. A better marker to detect coronary artery sclerosis. J Cardiol 2009, 54:359-367.
31. Curhan G., Cystatin C. A marker of renal function or something more. Clin Chem 2005, 51:293-294.